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Abstract

Go to:

Tumor thrombosis is a relatively uncommon complication of renal cell carcinoma (RCC), and its
diagnosis has therapeutic and prognostic implication. Computerized tomography (CT) is the primary
imaging modality for staging RCC, but it has low sensitivity to differentiate between tumor thrombus
and bland or benign thrombus. 18-fluorodeoxyglucose positron emission tomography/CT (PET/CT)
has a limited role in diagnosis and staging of RCC, but its diagnostic accuracy is considerably high for
detection of metabolically active tumor thrombus. We are presenting a case of metastatic left-sided
RCC with massive hypermetabolic tumor thrombus extending from left kidney to left renal vein and
inferior vena cava giving an interesting “Suspension Bridge” appearance on PET/CT images.
Keywords: 18-fluorodeoxyglucose positron emission tomography/computerized tomography, bland
thrombus, massive tumor thrombus, renal cell carcinoma

Introduction
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Renal cell carcinoma (RCC) is the most common solid tumor of the kidneys, accounting for 3% of all
malignancies and representing the seventh leading cause of cancer.[1] An unusual hallmark of RCC is
the biological predisposition for vascular invasion, with the extension of tumor thrombus into the renal
veins and inferior vena cava (IVC) in 24% and 12% of all cases, respectively.[2] Preoperative diagnosis
of tumor thrombosis and its extent is paramount as it needs surgical resection (nephrectomy and
thrombectomy) to have local control and prognostic implication as about 33% patients also have
concurrent metastasis.[1] RCC is also associated with hypercoagulable state and development of bland
IVC thrombus which usually do not require thrombectomy. The differentiation between tumor
thrombus and bland thrombus is not usually possible with contrast-enhanced computerized tomography
(CECT) or magnetic resonance imaging (MRI).[3] However, 18-flourodeoxyglucose (18FDG)-based
positron emission tomography/CT (PET/CT) imaging has the capability of accurate anatomical
localization of tumor spread and can differentiate between bland and tumor thrombus based on 18FDG
uptake by viable tumor cells.[4]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905257/
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We are presenting a case of the left RCC with extensive 18FDG tumor thrombus in the left renal vein
and IVC mimicking “Suspension Bridge” on PET/CT imaging.

Case Report
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A 72-year-old male presented with a history of painful sternal swelling and fine needle aspiration
biopsy was positive for metastatic cancer most like renal origin. An 18FDG PET/CT study was advised
for localization of primary tumor and staging. The patient was administered 190 MBq (3 MBq/kg) of
18FDG (fasting blood glucose 90 mg/dl), and after 55 min of uptake period, imaging was performed
using Celesteion, Toshiba, Japan. First a low-dose non-CECT (NCECT) scan was acquired from skull
to mid-thigh (Voltage: 140 kV; Current 80 mA: CT Dose Index volume [CTDIvolume]: 2.80 mGy)
followed by PET imaging in 3-D mode using 3 min/bed position in caudocranial direction. Images
revealed intense 18FDG uptake over left kidney extending into left renal vein and IVC with retrograde
and antegrade extension (T12–L2 level) mimicking a “Suspension Bridge Sign.” On NCECT images,
involved left renal vein and IVC segment were dilated with an ill-defined mass lesion in interpolar
region of left kidney [Figure 1]. Standardize uptake values (SUVmax) over left kidney, left renal vein,
and IVC were 10.9, 13.4, and 16.6 (Liver SUVmean2.08). In addition, there was 18FDG avid
destructive bony lesion involving the body of sternum. The patient underwent left nephrectomy, and
thrombectomy and histopathology revealed RCC with massive tumor thrombus extension into the left
renal vein and IVC.

Figure 1
18-fluorodeoxyglucose positron emission tomography/computerized tomography study (low-dose
noncontrast enhanced computerized tomography). (a) Fused coronal image showing hypermetabolic tumor
thrombus in left renal vein and inferior vena cava; (b) maximum intensity projection image showing
“Suspension Bridge Sign” appearance of hypermetabolic tumor thrombus in abdomen. Hypermetabolic
focus over lower chest represents sternal metastasis; (c-e) axial images showing hypermetabolic tumor
thrombus extending from left kidney to dilated inferior vena cava through dilated left renal vein
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905257/
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Discussion
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CECT is the imaging of choice for diagnosis and staging of RCC with a reported sensitivity of 92%.[5]
However, 18FDG PET/CT has a limited role for RCC as excreted 18FDG may obscure or mask the
lesions of the kidneys. Therefore, 18FDG PET/CT is not recommended for diagnosis and staging of
RCC in current guidelines.[6] In the management of RCC, detection of tumor thrombosis, its extent,
and differentiation between bland or venous thrombosis is important. Venous or bland thrombosis is
commonly seen in cancer which is managed with anticoagulant therapy, while tumor thrombosis
requires aggressive multimodality therapeutics. Differentiation between these two entities is important
for therapeutic and prognostic point of view which may not be possible with CECT or MRI.[3] Recent
data show that 18FDG PET/CT has higher sensitivity and diagnostic accuracy for detection of tumor
thrombosis and bony metastasis as compared with CT and bone scan, respectively.[7] IVC is the most
common site with a linear shaped 18FDG uptake by viable tumor thrombus. SUVmax of tumor
thrombus in our case was significantly high (renal vein: 13.4 and IVC: 16.6) which is in concordance
with published reports.[6] In the present case, hypermetabolic tumor thrombus was very extensive,
extending from left kidney passing through left renal vein and entering into IVC with antegrade
(infrahepatic) and retrograde extensions giving an appearance of suspension bridge on maximum
intensity projection and coronal images. To the best of our search, we could not find any report in
literature with such an extensive tumor thrombus in RCC giving this type of interesting appearance.
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